Press releases // 07 September 2017
IntegraGen Announces CE-IVD Marking of miRpredX 31-3p Kit
IntegraGen today announced the CE-IVD marking and commercial launch of its miRpredX 31-3p test kit in the E.U., the first positive theranostic test for patients with metastatic colorectal cancer.
Click here for press release
#content-main{display:none} For full functionality of this site it is necessary to (…) »